Analyst Price Targets — CCEL
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 4, 2025 1:18 pm | — | Maxim Group | $8.50 | $6.60 | TheFly | Cryo-Cell price target lowered to $8.50 from $9 at Maxim |
Latest News for CCEL
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in 1992, announced results for its fiscal year ended November 30, 2025. Financial Results Revenue Consolidated revenues for fiscal 2025 were $31.6 million compared to $32.0 million for fiscal 2024. The revenues for fiscal 2025 consisted of…
Shares of Cryo-Cell International Inc. (NYSEAMERICAN:CCEL - Get Free Report) crossed below its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $4.57 and traded as low as $3.57. Cryo-Cell International shares last traded at $3.59, with a volume of 3,917 shares traded. Analyst Ratings Changes Separately, Maxim
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CCEL.
U.S. House Trading
No House trades found for CCEL.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.